Syngenta Ag (SYT) 80.60 $SYT Agricultural Chemicals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Syngenta Ag (SYT) 80.60 $SYT

Agricultural Chemicals Industry's Stocks Get Research Review
ACCESSWIRE - Fri Jun 10, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 10, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Agricultural Chemicals industry. Companies recently under review include E. I. du Pont de Nemours, Intrepid Potash, Syngenta, and Ceres. Register with us now for your free membership and see our complete reports on these equities at:
SYT: 80.60 (-0.57), CERE: 0.22 (-0.03), DD: 66.75 (-0.81), IPI: 1.50 (+0.23)

ETFs to Watch on Monsanto Buyout Offer
Sweta Killa - Zacks Investment Research - Tue May 24, 8:46AM CDT
The German chemical giant made all-cash bid to acquire Monsanto for $62 billion, including debt, putting these ETFs on spotlight.
XLB: 47.21 (-0.53), SYT: 80.60 (-0.57), MON: 107.05 (-2.15), MOO: 48.40 (-0.65), VEGI: 23.76 (-0.86), IYM: 77.65 (-0.95), DD: 66.75 (-0.81), DOW: 52.69 (-0.69)

Syngenta Down to Sell on Unfavorable Business Environment
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:45AM CDT
On May 19, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold).
SYT: 80.60 (-0.57), AG: 12.59 (+0.13), BHP: 26.85 (+0.12)

Company News for May 18, 2016
Zacks Equity Research - Zacks Investment Research - Wed May 18, 9:10AM CDT
Companies in the News are: ALK,VA,HTZ,ODP,SPLS,SYT
SPLS: 8.63 (-0.08), HTZ: 10.50 (-0.18), SYT: 80.60 (-0.57), VA: 56.01 (-0.01), ODP: 3.47 (-0.03), ALK: 64.29 (-2.63)

Nutritional Experts Laud Nutrient Rich & Naturally Harvested Ingredients such as Eco-Friendly Moringa; Company Enters JV to Meet Growing Moringa Demand
PR Newswire - Thu May 05, 7:30AM CDT
Nutrient rich & eco-friendly ingredients appear to not only be fuel for the human body, but also the agricultural sector as companies race to develop advancing, naturally harvested components. With new, JV projects, research and products being introduced daily, companies with current developments of note in the markets today are New Global Energy, Inc. (OTC: NGEY), Monsanto Company (NYSE: MON), Syngenta AG (NYSE: SYT) DuPont Co. (NYSE: DD) & Agrium Inc. (AGU).
SYT: 80.60 (-0.57), MON: 107.05 (-2.15), AGU: 93.64 (-0.28), DD: 66.75 (-0.81)

Syngenta Annual General Meeting
PR Newswire - Tue Apr 26, 7:30AM CDT
At the Annual General Meeting of Syngenta AG held on April 26, 2016, the 1337 shareholders representing 50.68% of the total shares approved all the motions proposed by the Board of Directors.
SYT: 80.60 (-0.57)

Look for Shares of Syngenta to Potentially Rebound after Yesterday's 1.21% Sell Off
Comtex SmarTrend(R) - Fri Apr 22, 1:34PM CDT
Syngenta (NYSE:SYT) traded in a range yesterday that spanned from a low of $82.08 to a high of $82.70. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $82.76 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SYT: 80.60 (-0.57)

BioControl Agents Market By Active Substance (Microbials, Macrobials,); By Application (Seed Treatment, On-Field); By Environment; By Crop (Cereals & Grains, Vegetables & Fruits); By Target Pest (Arthropods, Weeds, Micro-organisms) -Forecast (2015 - 2020)
PR Newswire - Thu Apr 21, 6:02PM CDT
BioControl Agents (BCAs) are beneficial organisms that assist farmers in pest control and plant growth. BCA is one of the emerging trends in the crop protection industry supporting the wider trend of non-chemical pest control. This market encompasses a wide variety of natural enemies which combat different pests in several crop fields. Providers of these products assist the growers in choosing and release of specific BioControl product. Increasing concern on soil fertility, environmental and food contamination related to excess use of chemical pesticides is one of the primary factors that have been driving the growth of this market. However, lack of enough awareness and knowledge among growers regarding these environmental friendly and effective pest control mechanisms hinders the reach of BioControl products. The global BCAs market has been analyzed with respect to different parameters such as demand, supply, end-users and providers of BCAs. BCAs market encompasses several types of organisms which differ in size and mode of action. On the basis of active substance, the report is segmented into Microbials, Macrobials, Entomopathogenic nematodes. Microbials are mostly preferred by the out-field growers due to their wide availability, lower cost and their potential to suppress various pests. Beneficial insects are provided in packages which are placed in the field to facilitate their release whereas, microbial products are offered in the form of liquid or granules that are typically distributed through standardized agricultural equipment. The overall market is also presented from the perspective of different geographic regions and the key countries in each region. North America is the dominant market which held more than one-third share in 2014 and is estimated to be the fastest growing, mainly driven by escalating preference among growers and increasing penetration of IPM practices in the agricultural system of this region. Currently, the BioControl Agents segment accounts to 3%-4% of the global pest control market. The global BCAs market is estimated to reach $2,871.6m by 2020 at a CAGR of 13.1%. On-field is the largest application for BCAs primarily driven by the use of beneficial insects, followed by seed treatment based on micro-organisms based on fungi and bacteria. BCAs market is dominated by five major companies, namely: Bayer CropScience AG, BASF SE (Germany), Syngenta AG (Switzerland), Novozymes A/S (Denmark) and Koppert Biological systems (Netherlands), all of these companies together held a major market share in 2014.These companies have significant presence in the BCAs market with wide product mix and considerable brand image. Other major players in this market include: Monsanto Company Inc. (U.S.), Biobest N.V. and Marrone BioInnovations Inc. (U.S.).
SYT: 80.60 (-0.57), MON: 107.05 (-2.15)

Syngenta Posts Lackluster Q1 Trading Results, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 21, 10:13AM CDT
Premium agricultural chemicals company Syngenta AG (SYT) reported weak trading results for first-quarter 2016.
SYT: 80.60 (-0.57), EGO: 4.45 (-0.01), AGI: 7.68 (-0.19), APD: 144.03 (-2.36)

Sulphur Coated Urea Market: Global Industry Analysis 2015-2025 - Key Players are Agrium Inc., Harrell's LLC & Syngenta AG - Research and Markets
BusinessWire - Mon Apr 18, 8:00AM CDT
Research and Markets has announced the addition of the "Sulphur Coated Urea Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
SYT: 80.60 (-0.57)

Syngenta Downgraded to Hold on Agro-Industry Headwinds
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:45PM CDT
On Apr 13, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
SYT: 80.60 (-0.57), LMNR: 18.81 (+0.73), AU: 16.22 (-0.44), AGI: 7.68 (-0.19)

Monsanto (MON) Faces Macro Risks: Dump the Stock Now?
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 12:55PM CDT
On Apr 11, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company (MON).
MON: 107.05 (-2.15), SYT: 80.60 (-0.57), LMNR: 18.81 (+0.73), AGI: 7.68 (-0.19)

Monsanto Misses Q2 Earnings Estimates, Cuts FY16 Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 10:02AM CDT
Monsanto Company (MON) reported disappointing results for second-quarter fiscal 2016 (ended Feb 29, 2016).
MON: 107.05 (-2.15), SYT: 80.60 (-0.57), LMNR: 18.81 (+0.73), AGI: 7.68 (-0.19)

Syngenta (SYT) Poised to Grow Amid Headwinds: Buy Now?
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:45PM CDT
On Mar 14, 2016, we issued an updated research report on Syngenta AG (SYT).
FSM: 6.44 (-0.06), AUMN: 0.49 (+0.03), SYT: 80.60 (-0.57), ASM: 2.29 (+0.20)

Monsanto's New Deals to Widen Climate FieldView's Reach
Zacks Equity Research - Zacks Investment Research - Mon Mar 07, 12:20PM CST
Monsanto Company (MON) recently proclaimed that Climate Corporation has inked data connectivity agreements with many retailer and agronomic software systems.
AUMN: 0.49 (+0.03), MON: 107.05 (-2.15), SYT: 80.60 (-0.57), AU: 16.22 (-0.44)

3 Reasons Monsanto Stock Could Rise
Dan Caplinger, The Motley Fool - Motley Fool - Sun Mar 06, 6:20AM CST
Image: Monsanto. The past year has been a tough one for the agricultural industry, and Monsanto has seen its stock lose almost a quarter of its value since early 2015. Poor prices for commodity crops have taken their toll on demand from farmers,...
SYT: 80.60 (-0.57), MON: 107.05 (-2.15), DE: 85.32 (-0.35)

This FDA Test Could Devastate Monsanto Inc.
Rich Duprey, The Motley Fool - Motley Fool - Sat Mar 05, 6:50AM CST
The FDA will begin testing our food supply for traces of glyphosate, the active ingredient in Monsanto's Roundup herbicide. Image source: Horia Varlan . Uh-oh. This can't be good for Monsanto . As if the chemicals giant didn't have enough on its...
SYT: 80.60 (-0.57), MON: 107.05 (-2.15), CPB: 62.12 (-0.58), DOW: 52.69 (-0.69)

Syngenta's 2015 Earnings & Revenues Fall Y/Y, Shares Slide
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 12:00PM CST
Syngenta AG (SYT) recently reported weak financial results for full-year 2015 (ended Dec 31, 2015).
CZZ: 5.79 (-0.24), SYT: 80.60 (-0.57), AEM: 51.43 (+0.84), ABX: 20.22 (+0.61)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading